The new treatment involves administering a single injection of adult donor bone marrow stem cells into a patient’s degenerative disc. The technology could regenerate the deteriorating intervertebral disc and reverse damage to the spine.
Mesoblast, a global medical device company, will sponsor the trial.
Related Articles on Pain Management:
Opioid Pain Reliever Overdose Kills More Than Heroin and Cocaine Combined
Oregon’s High Rate of Pain Drug Abuse Linked to Heavy Prescribing
Opioid Abuse Increasing in Older White Women
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.